Table 5.
Comparisons of ceruloplasmin hepatitis B virus with other predictive models for assessing F ≥ 2 (n = 275)
| Model | AUC (95%CI) | Youden index | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | P value |
| CPHBV | 0.839 (0.792-0.886) | 0.512 | 80.1 | 71.1 | 76.2 | 72.4 | |
| APRI | 0.704 (0.639-0.768) | 0.355 | 75.9 | 59.6 | 68.5 | 66.1 | < 0.001 |
| FIB-4 | 0.678 (0.612-0.745) | 0.330 | 71.9 | 61.4 | 68.8 | 64.2 | < 0.001 |
| GPR | 0.704 (0.640-0.768) | 0.350 | 74.5 | 60.5 | 70.1 | 66.7 | < 0.001 |
| Forn’s index | 0.687 (0.622-0.753) | 0.359 | 63.1 | 72.8 | 74.2 | 61.5 | < 0.001 |
| S-index | 0.722 (0.659-0.784) | 0.357 | 78.7 | 57.0 | 69.9 | 69.7 | 0.0034 |
AUC: Area under the receiver operating characteristic curve; NPV: Negative predictive value; PPV: Positive predictive value; CPHBV: Ceruloplasmin hepatitis B virus; APRI: Aspartate aminotransferase-to-platelet ratio index; FIB-4: Fibrosis-4; GPR: Gamma-glutamyl transpeptidase-to-platelet ratio.